216 related articles for article (PubMed ID: 27666873)
1. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems.
AbouSamra MM; Salama AH
J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873
[TBL] [Abstract][Full Text] [Related]
2. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis].
Yamaguchi H; Uchida K; Tanaka T; Yamaguchi T
Jpn J Antibiot; 2001 Jun; 54(6):323-30. PubMed ID: 11521512
[TBL] [Abstract][Full Text] [Related]
4. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
5. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Kumar N; Shishu
Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
7. Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model.
Kumar N; Goindi S
Int J Pharm; 2014 Sep; 472(1-2):224-40. PubMed ID: 24954723
[TBL] [Abstract][Full Text] [Related]
8. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation.
Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ
Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
10. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery.
Sudhakar B; Varma JN; Murthy KV
Curr Drug Deliv; 2014; 11(4):521-30. PubMed ID: 24410098
[TBL] [Abstract][Full Text] [Related]
11. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
Korting HC; Kiencke P; Nelles S; Rychlik R
Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
[TBL] [Abstract][Full Text] [Related]
12. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
[TBL] [Abstract][Full Text] [Related]
13. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
14. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
15. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
Garg BJ; Garg NK; Beg S; Singh B; Katare OP
J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
[TBL] [Abstract][Full Text] [Related]
16. Provesicular elastic carriers of Simvastatin for enhanced wound healing activity: An in-vitro/in-vivo study.
Abd El-Alim SH; Salama A; Darwish AB
Int J Pharm; 2020 Jul; 585():119470. PubMed ID: 32464234
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine.
AbouSamra MM; Salama AH; Awad GEA; Mansy SS
AAPS PharmSciTech; 2020 Oct; 21(7):283. PubMed ID: 33051708
[TBL] [Abstract][Full Text] [Related]
18. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
Kaur M; Singh K; Jain SK
J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
[TBL] [Abstract][Full Text] [Related]
19. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.
Aburahma MH; Abdelbary GA
Int J Pharm; 2012 Jan; 422(1-2):139-50. PubMed ID: 22079716
[TBL] [Abstract][Full Text] [Related]
20. Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis.
Fuerst JF; Cox GF; Weaver SM; Duncan WC
Cutis; 1980 May; 25(5):544-6, 549. PubMed ID: 6991217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
